We are live on ! Find out more
KIDS icon

OrthoPediatrics

131 hedge funds and large institutions have $864M invested in OrthoPediatrics in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 40 increasing their positions, 53 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

1.77% less ownership

Funds ownership: 75.18%73.41% (-1.8%)

8% less funds holding

Funds holding: 143131 (-12)

10% less capital invested

Capital invested by funds: $965M → $864M (-$101M)

25% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 53

57% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 21

99% less call options, than puts

Call options by funds: $72K | Put options by funds: $11.2M

Holders
131
Holders Change
-12
Holders Change %
-8.39%
% of All Funds
2.02%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
9
Increased
40
Reduced
53
Closed
21
Calls
$72K
Puts
$11.2M
Net Calls
-$11.1M
Net Calls Change
-$242K
Name Holding Trade Value Shares
Change
Change in
Stake
BCM
1
Brown Capital Management
Maryland
$162M -$1.7M -27,372 -1%
RP
2
Riverbridge Partners
Minnesota
$66.2M +$2.14M +34,358 +3%
Brown Advisory
3
Brown Advisory
Maryland
$64M -$260K -4,171 -0.4%
BlackRock
4
BlackRock
New York
$56.1M -$240K -3,858 -0.4%
Vanguard Group
5
Vanguard Group
Pennsylvania
$43.8M +$172K +2,761 +0.4%
NCGI
6
Next Century Growth Investors
Minnesota
$32.5M +$1.9M +30,532 +6%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$31.4M +$1.44M +23,179 +5%
WA
8
Wasatch Advisors
Utah
$29.9M +$280K +4,503 +0.9%
SPPAM
9
Summit Partners Public Asset Management
Massachusetts
$26.1M +$2.8M +44,973 +11%
Invesco
10
Invesco
Georgia
$25M -$553K -8,879 -2%
New York State Common Retirement Fund
11
New York State Common Retirement Fund
New York
$23M +$587K +9,437 +3%
DDC
12
DF Dent & Co
Maryland
$22.4M -$4.09M -65,679 -15%
State Street
13
State Street
Massachusetts
$22.3M -$653K -10,496 -3%
Allspring Global Investments
14
Allspring Global Investments
North Carolina
$21M +$21.8M +350,461 New
AIC
15
AWM Investment Company
New York
$17.8M -$12.4K -200 -0.1%
Lord, Abbett & Co
16
Lord, Abbett & Co
New Jersey
$17.8M -$178K -2,855 -1%
GIM
17
Granahan Investment Management
Massachusetts
$15.6M +$5.04M +80,945 +45%
Dimensional Fund Advisors
18
Dimensional Fund Advisors
Texas
$15.4M +$1.45M +23,333 +10%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$14.6M -$441K -7,078 -3%
FLAM
20
First Light Asset Management
Minnesota
$14.2M +$305K +4,893 +2%
Northern Trust
21
Northern Trust
Illinois
$13.8M -$289K -4,635 -2%
RA
22
Royce & Associates
New York
$8.79M -$73.3K -1,177 -0.8%
FG
23
Formula Growth
Quebec, Canada
$7.94M -$152K -2,434 -2%
LCG
24
Lisanti Capital Growth
New York
$6.16M -$29.9K -480 -0.5%
Charles Schwab
25
Charles Schwab
California
$5.87M +$70.3K +1,130 +1%

KIDS Hedge Fund Activity: Q4 2021 in Review

131 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in OrthoPediatrics (KIDS) for Q4 2021, worth a combined $864M — down 10% from $965M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of KIDS and 9 opened new positions — a net loss of 12 holders — while 53 trimmed existing stakes and 40 added.

The largest buyer was Granahan Investment Management, adding an estimated $5.04M. The largest seller was Wells Fargo, cutting an estimated $22.2M.

  • 131 institutional investors held OrthoPediatrics (KIDS) as of Q4 2021, down from 143 in Q3 2021.
  • Funds reported $864M of OrthoPediatrics stock for Q4 2021, down 10% quarter-over-quarter.
  • 9 funds opened new OrthoPediatrics positions in Q4 2021 and 21 closed out, a net change of -12 holders.
  • The largest OrthoPediatrics buyer in Q4 2021 was Granahan Investment Management, an estimated $5.04M added.
  • The largest OrthoPediatrics seller in Q4 2021 was Wells Fargo, an estimated $22.2M sold.

Based on aggregated 13F filings for Q4 2021.